Vanguard Capital Management »

Summit Therapeutics shares owned by Vanguard Capital Management

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Vanguard Capital Management from 13F filings

Historical chart of Vanguard Capital Management investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Vanguard Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Vanguard Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $108M 5.7M 18.96